Drugs / Smokeless Tobacco
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06315881 | Jan 2025 → Jan 2028 expected | cancer | Ohio State University Comprehensive Cancer Center | Recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00313105 | Apr 2006 → Apr 2010 | nicotine dependence | University Hospital, Gentofte, Copenhagen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Smokeless Tobacco | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06315881 ↗ |
| Known as | Oliver Twist pellets | “Smokeless tobacco (Oliver Twist pellets)” NCT00313105 ↗ |